IBDEI01S ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1829,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,1829,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,1829,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,1830,0)
 ;;=V16.42^^9^91^10
 ;;^UTILITY(U,$J,358.3,1830,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1830,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,1830,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,1830,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,1831,0)
 ;;=V16.43^^9^91^11
 ;;^UTILITY(U,$J,358.3,1831,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1831,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,1831,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,1831,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,1832,0)
 ;;=V19.5^^9^91^13
 ;;^UTILITY(U,$J,358.3,1832,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1832,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,1832,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,1832,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,1833,0)
 ;;=V19.2^^9^91^14
 ;;^UTILITY(U,$J,358.3,1833,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1833,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,1833,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,1833,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,1834,0)
 ;;=V17.3^^9^91^16
 ;;^UTILITY(U,$J,358.3,1834,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1834,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,1834,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,1834,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,1835,0)
 ;;=V16.6^^9^91^17
 ;;^UTILITY(U,$J,358.3,1835,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1835,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,1835,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,1835,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,1836,0)
 ;;=V18.61^^9^91^19
 ;;^UTILITY(U,$J,358.3,1836,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1836,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,1836,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,1836,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,1837,0)
 ;;=V17.0^^9^91^20
 ;;^UTILITY(U,$J,358.3,1837,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1837,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,1837,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,1837,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,1838,0)
 ;;=V19.4^^9^91^21
 ;;^UTILITY(U,$J,358.3,1838,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1838,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,1838,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,1838,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,1839,0)
 ;;=V17.1^^9^91^22
 ;;^UTILITY(U,$J,358.3,1839,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1839,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,1839,1,5,0)
 ;;=5^Family h/o Stroke (CVA)
 ;;^UTILITY(U,$J,358.3,1839,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,1840,0)
 ;;=V16.8^^9^91^12
 ;;^UTILITY(U,$J,358.3,1840,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1840,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,1840,1,5,0)
 ;;=5^Family h/o Cancer,Other Specified
 ;;^UTILITY(U,$J,358.3,1840,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,1841,0)
 ;;=V11.1^^9^91^24
 ;;^UTILITY(U,$J,358.3,1841,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1841,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,1841,1,5,0)
 ;;=5^Hx of Affective Disorder
 ;;^UTILITY(U,$J,358.3,1841,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,1842,0)
 ;;=V15.89^^9^91^46
 ;;^UTILITY(U,$J,358.3,1842,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1842,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,1842,1,5,0)
 ;;=5^Hx of Persian Gulf Region Exposure
 ;;^UTILITY(U,$J,358.3,1842,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,1843,0)
 ;;=V11.3^^9^91^25
 ;;^UTILITY(U,$J,358.3,1843,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1843,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,1843,1,5,0)
 ;;=5^Hx of Alcoholism
 ;;^UTILITY(U,$J,358.3,1843,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,1844,0)
 ;;=V15.07^^9^91^26
 ;;^UTILITY(U,$J,358.3,1844,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1844,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,1844,1,5,0)
 ;;=5^Hx of Allergy to Latex
 ;;^UTILITY(U,$J,358.3,1844,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,1845,0)
 ;;=V13.4^^9^91^27
 ;;^UTILITY(U,$J,358.3,1845,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1845,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,1845,1,5,0)
 ;;=5^Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,1845,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,1846,0)
 ;;=V12.72^^9^91^31
 ;;^UTILITY(U,$J,358.3,1846,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1846,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,1846,1,5,0)
 ;;=5^Hx of Colon Polyps
 ;;^UTILITY(U,$J,358.3,1846,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,1847,0)
 ;;=V12.59^^9^91^30
 ;;^UTILITY(U,$J,358.3,1847,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1847,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,1847,1,5,0)
 ;;=5^Hx of CHF
 ;;^UTILITY(U,$J,358.3,1847,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,1848,0)
 ;;=V45.81^^9^91^29
 ;;^UTILITY(U,$J,358.3,1848,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1848,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,1848,1,5,0)
 ;;=5^Hx of CABG
 ;;^UTILITY(U,$J,358.3,1848,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,1849,0)
 ;;=V15.84^^9^91^28
 ;;^UTILITY(U,$J,358.3,1849,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1849,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,1849,1,5,0)
 ;;=5^Hx of Asbestos Exposure
 ;;^UTILITY(U,$J,358.3,1849,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,1850,0)
 ;;=V15.85^^9^91^47
 ;;^UTILITY(U,$J,358.3,1850,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1850,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,1850,1,5,0)
 ;;=5^Hx of Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,1850,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,1851,0)
 ;;=V10.72^^9^91^34
 ;;^UTILITY(U,$J,358.3,1851,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1851,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,1851,1,5,0)
 ;;=5^Hx of Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,1851,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,1852,0)
 ;;=V15.3^^9^91^35
 ;;^UTILITY(U,$J,358.3,1852,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1852,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,1852,1,5,0)
 ;;=5^Hx of Irradiation
 ;;^UTILITY(U,$J,358.3,1852,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,1853,0)
 ;;=V10.61^^9^91^37
 ;;^UTILITY(U,$J,358.3,1853,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1853,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,1853,1,5,0)
 ;;=5^Hx of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,1853,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,1854,0)
 ;;=V12.03^^9^91^39
 ;;^UTILITY(U,$J,358.3,1854,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1854,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,1854,1,5,0)
 ;;=5^Hx of Malaria
 ;;^UTILITY(U,$J,358.3,1854,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,1855,0)
 ;;=V10.82^^9^91^40
 ;;^UTILITY(U,$J,358.3,1855,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1855,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,1855,1,5,0)
 ;;=5^Hx of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,1855,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,1856,0)
 ;;=V10.62^^9^91^43
 ;;^UTILITY(U,$J,358.3,1856,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1856,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,1856,1,5,0)
 ;;=5^Hx of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,1856,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,1857,0)
 ;;=V10.63^^9^91^41
 ;;^UTILITY(U,$J,358.3,1857,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1857,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,1857,1,5,0)
 ;;=5^Hx of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,1857,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,1858,0)
 ;;=V11.2^^9^91^32
 ;;^UTILITY(U,$J,358.3,1858,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1858,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,1858,1,5,0)
 ;;=5^Hx of Dysthymia
 ;;^UTILITY(U,$J,358.3,1858,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,1859,0)
 ;;=V15.81^^9^91^60
 ;;^UTILITY(U,$J,358.3,1859,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1859,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,1859,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,1859,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,1860,0)
 ;;=V10.43^^9^91^44
 ;;^UTILITY(U,$J,358.3,1860,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1860,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,1860,1,5,0)
 ;;=5^Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,1860,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,1861,0)
 ;;=V12.71^^9^91^45
 ;;^UTILITY(U,$J,358.3,1861,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1861,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,1861,1,5,0)
 ;;=5^Hx of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,1861,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,1862,0)
 ;;=V10.46^^9^91^48
 ;;^UTILITY(U,$J,358.3,1862,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1862,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,1862,1,5,0)
 ;;=5^Hx of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,1862,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,1863,0)
 ;;=V11.0^^9^91^50
 ;;^UTILITY(U,$J,358.3,1863,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1863,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,1863,1,5,0)
 ;;=5^Hx of Schizophrenia
 ;;^UTILITY(U,$J,358.3,1863,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,1864,0)
 ;;=V10.83^^9^91^51
 ;;^UTILITY(U,$J,358.3,1864,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1864,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,1864,1,5,0)
 ;;=5^Hx of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,1864,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,1865,0)
 ;;=V15.1^^9^91^53
 ;;^UTILITY(U,$J,358.3,1865,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1865,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,1865,1,5,0)
 ;;=5^Hx of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,1865,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,1866,0)
 ;;=V15.82^^9^91^57
 ;;^UTILITY(U,$J,358.3,1866,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1866,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,1866,1,5,0)
 ;;=5^Hx of Tobacco Use (not current)
